Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization

Matthew Whiting, Jonathan C. Tripp, Ying Chuan Lin, William Lindstrom, Arthur J. Olson, John H. Elder, K. Barry Sharpless, Valery V. Fokin

Research output: Contribution to journalArticle

171 Citations (Scopus)

Abstract

Building from the results of a computational screen of a range of triazole-containing compounds for binding efficiency to human immunodeficiency virus type 1 protease (HIV-1-Pr), a novel series of potent inhibitors has been developed. The copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC), which provides ready access to 1,4-disubstituted-1,2,3-triazoles, was used to unite a focused library of azide-containing fragments with a diverse array of functionalized alkyne-containing building blocks. In combination with direct screening of the crude reaction products, this method led to the rapid identification of a lead structure and readily enabled optimization of both azide and alkyne fragments. Replacement of the triazole with a range of alternative linkers led to greatly reduced protease inhibition; however, further functionalization of the triazoles at the 5-position gave a series of compounds with increased activity, exhibiting Ki values as low as 8 nM.

Original languageEnglish
Pages (from-to)7697-7710
Number of pages14
JournalJournal of Medicinal Chemistry
Volume49
Issue number26
DOIs
Publication statusPublished - 28 Dec 2006
Externally publishedYes

Fingerprint

Triazoles
Viruses
Alkynes
Azides
HIV-1
Copper
Peptide Hydrolases
Cycloaddition
Cycloaddition Reaction
Reaction products
Screening

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization. / Whiting, Matthew; Tripp, Jonathan C.; Lin, Ying Chuan; Lindstrom, William; Olson, Arthur J.; Elder, John H.; Sharpless, K. Barry; Fokin, Valery V.

In: Journal of Medicinal Chemistry, Vol. 49, No. 26, 28.12.2006, p. 7697-7710.

Research output: Contribution to journalArticle

Whiting, Matthew ; Tripp, Jonathan C. ; Lin, Ying Chuan ; Lindstrom, William ; Olson, Arthur J. ; Elder, John H. ; Sharpless, K. Barry ; Fokin, Valery V. / Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization. In: Journal of Medicinal Chemistry. 2006 ; Vol. 49, No. 26. pp. 7697-7710.
@article{21c169e689bb4889a58d66e202cac009,
title = "Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization",
abstract = "Building from the results of a computational screen of a range of triazole-containing compounds for binding efficiency to human immunodeficiency virus type 1 protease (HIV-1-Pr), a novel series of potent inhibitors has been developed. The copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC), which provides ready access to 1,4-disubstituted-1,2,3-triazoles, was used to unite a focused library of azide-containing fragments with a diverse array of functionalized alkyne-containing building blocks. In combination with direct screening of the crude reaction products, this method led to the rapid identification of a lead structure and readily enabled optimization of both azide and alkyne fragments. Replacement of the triazole with a range of alternative linkers led to greatly reduced protease inhibition; however, further functionalization of the triazoles at the 5-position gave a series of compounds with increased activity, exhibiting Ki values as low as 8 nM.",
author = "Matthew Whiting and Tripp, {Jonathan C.} and Lin, {Ying Chuan} and William Lindstrom and Olson, {Arthur J.} and Elder, {John H.} and Sharpless, {K. Barry} and Fokin, {Valery V.}",
year = "2006",
month = "12",
day = "28",
doi = "10.1021/jm060754+",
language = "English",
volume = "49",
pages = "7697--7710",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "26",

}

TY - JOUR

T1 - Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization

AU - Whiting, Matthew

AU - Tripp, Jonathan C.

AU - Lin, Ying Chuan

AU - Lindstrom, William

AU - Olson, Arthur J.

AU - Elder, John H.

AU - Sharpless, K. Barry

AU - Fokin, Valery V.

PY - 2006/12/28

Y1 - 2006/12/28

N2 - Building from the results of a computational screen of a range of triazole-containing compounds for binding efficiency to human immunodeficiency virus type 1 protease (HIV-1-Pr), a novel series of potent inhibitors has been developed. The copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC), which provides ready access to 1,4-disubstituted-1,2,3-triazoles, was used to unite a focused library of azide-containing fragments with a diverse array of functionalized alkyne-containing building blocks. In combination with direct screening of the crude reaction products, this method led to the rapid identification of a lead structure and readily enabled optimization of both azide and alkyne fragments. Replacement of the triazole with a range of alternative linkers led to greatly reduced protease inhibition; however, further functionalization of the triazoles at the 5-position gave a series of compounds with increased activity, exhibiting Ki values as low as 8 nM.

AB - Building from the results of a computational screen of a range of triazole-containing compounds for binding efficiency to human immunodeficiency virus type 1 protease (HIV-1-Pr), a novel series of potent inhibitors has been developed. The copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC), which provides ready access to 1,4-disubstituted-1,2,3-triazoles, was used to unite a focused library of azide-containing fragments with a diverse array of functionalized alkyne-containing building blocks. In combination with direct screening of the crude reaction products, this method led to the rapid identification of a lead structure and readily enabled optimization of both azide and alkyne fragments. Replacement of the triazole with a range of alternative linkers led to greatly reduced protease inhibition; however, further functionalization of the triazoles at the 5-position gave a series of compounds with increased activity, exhibiting Ki values as low as 8 nM.

UR - http://www.scopus.com/inward/record.url?scp=33845939348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845939348&partnerID=8YFLogxK

U2 - 10.1021/jm060754+

DO - 10.1021/jm060754+

M3 - Article

VL - 49

SP - 7697

EP - 7710

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 26

ER -